These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6746547)

  • 1. Effect of intravenous propranolol on portal hypertension.
    Gupta KM; Chadda S; Chadda VS; Panwar RB; Sharda DP; Mishra SN; Chaudhary A
    J Assoc Physicians India; 1984 Apr; 32(4):343-4. PubMed ID: 6746547
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheohepatogram as a parameter in assessing immediate effects of propranolol on portal hypertension.
    Wu XN; Gu JK; Wang GL; Ding MM
    Chin Med J (Engl); 1986 Jan; 99(1):27-31. PubMed ID: 3089702
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol effect on portal hypertension.
    Ozsoylu S
    Hepatology; 1988; 8(3):707. PubMed ID: 3371890
    [No Abstract]   [Full Text] [Related]  

  • 4. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Inderal on certain hemodynamic indices in arterial hypertension].
    Kocemba J; Dubiel J; Gabryś B
    Pol Tyg Lek; 1970 Aug; 25(34):1280-2. PubMed ID: 5507157
    [No Abstract]   [Full Text] [Related]  

  • 6. Propranolol in portal hypertension.
    Lancet; 1981 May; 1(8231):1204. PubMed ID: 6112540
    [No Abstract]   [Full Text] [Related]  

  • 7. Propranolol in portal hypertension.
    Menghini G
    Hepatology; 1983; 3(3):466. PubMed ID: 6840693
    [No Abstract]   [Full Text] [Related]  

  • 8. Propranolol in portal hypertension.
    Lacaine F
    Hepatology; 1983; 3(4):622-3. PubMed ID: 6345334
    [No Abstract]   [Full Text] [Related]  

  • 9. [Addition of ritanserin to the treatment with propranolol in cirrhotic patients: effects on portal pressure].
    Ladero Quesada JM; Díez Ordóñez S; Gallego Beuter JJ; Hernández Lezana A; Herraiz Serrano ML; Díaz-Rubio García M
    An Med Interna; 1994 Apr; 11(4):162-6. PubMed ID: 8043734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Propranolol treatment of hemorrhage due to portal hypertension].
    Bleichner G; Parent A; Raffray Y; Squara P
    Nouv Presse Med; 1981 Mar; 10(13):1072-3. PubMed ID: 6971437
    [No Abstract]   [Full Text] [Related]  

  • 11. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
    Baik SK; Park DH; Kim MY; Choi YJ; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ
    J Gastroenterol; 2003; 38(12):1150-4. PubMed ID: 14714252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters.
    Gitlin N
    Am J Gastroenterol; 1983 Feb; 78(2):124-6. PubMed ID: 6823937
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of propranolol in portal hypertension. Conventional and long acting formulations.
    Hayes PC
    Drugs; 1989; 37 Suppl 2():70-3; discussion 74-6. PubMed ID: 2680433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options in portal hypertension: Does propranolol have a role? Proceedings of a satellite symposium of the XIII International Congress of Gastroenterology and the VI European Congress of Digestive Endoscopy. Rome, 9 September 1988.
    Drugs; 1989; 37 Suppl 2():1-73. PubMed ID: 2806132
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical therapy of portal hypertension].
    Baldassarre G; Ventrella F; Gadaleta CD
    Clin Ter; 1986 May; 117(4):355-60. PubMed ID: 3731740
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of intravenous and intrasplenic pituitrin in portal hypertension.
    Shah CP; Shah SN; Shah BR; Sanghavi NG
    J Assoc Physicians India; 1969 Jun; 17(6):359-62. PubMed ID: 5347672
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of frusemide in the management of portal hypertension. A preliminary report.
    Nooman ZM; el-Rooby A; Nafeh ME
    J Egypt Med Assoc; 1970; 53(2):113-7. PubMed ID: 5474641
    [No Abstract]   [Full Text] [Related]  

  • 20. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.